/* mobile /* end mobile MEDDESKTOP: CoGenesys Inc. Acquired By Teva Pharmaceutical Industries Ltd.

Tuesday, January 22, 2008

CoGenesys Inc. Acquired By Teva Pharmaceutical Industries Ltd.

Generic-drug giant Teva Pharmaceutical Industries Ltd. has agreed to acquire biopharmaceutical company CoGenesys Inc. for $400 million in cash, Teva announced Tuesday.

The deal, which is expected to close during the first half of 2008, is likely to stoke the debate about the role generic-drug makers should play in the emerging market for biological therapies.

CoGenesys Inc., a closely held spinoff of Human Genome Sciences Inc., would give Jerusalem-based Teva a foothold in the market for biologic therapies.

News Source,

tag: , ,

No comments:

LinkWithin

Related Posts Widget for Blogs by LinkWithin